Biomedical HIV prevention research and epidemic control in Thailand: Two sides of the same coin

Sexual Health

Volumn 11, Issue 2, 2014, Pages 180-199

  Van Griensven, Frits ^a,b,c   Phanuphak, Nittaya ^a   Srithanaviboonchai, Kriengkrai ^d  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

antiretroviral treatment; condom use; injecting drug users; prophylaxis; sex workers; vaccination

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIVIRAL THERAPY; DRUG USE; EPIDEMIC; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEN WHO HAVE SEX WITH MEN; POLITICS; PROSTITUTION; REVIEW; THAILAND; TRANSGENDERISM;

EID: 84904369857     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH13119     Document Type: Review

References (177)

1. United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP). Statistical yearbook for Asia and the Pacific, 2011. Bangkok: UNESCAP; 2011. Available online at: http://www.unescap.org/stat/data/syb2011/I- People/Financialand- human-resources-for-health.asp [verified July 2013].
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). World AIDS Day report 2012. Geneva: UNAIDS; 2013.
3. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994; 344: 243-5. doi:10.1016/ S0140-6736(94)93004- X
4. Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS 1996; 10: 1-7. doi:10.1097/00002030-199601000- 00001
5. World Health Organization (WHO). Experiences of the 100% condom use program in selected countries in Asia. Manila: WHO; 2004.
6. The World Bank. Thailand's response to AIDS: building on success, confronting the future. Washington DC: Thailand Social Monitor V; 2000. Available online at: http://siteresources.worldbank.org/ INTTHAILAND/Resources/ Social-Monitor/2000nov.pdf [verified August 2013].
7. Punpanich W, Ungchusak K, Detels R. Thailand's response to the HIV epidemic. Yesterday, today and tomorrow. AIDS Educ Prev 2004; 16: 119-36. doi:10.1521/aeap.16.3.5.119.35520
8. Rojanapithayakorn W. The 100% condom use programme in Asia. Reprod Health Matters 2006; 14: 41-52. doi:10.1016/S0968-8080 (06)28270-3
9. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999; 353: 773-80. doi:10.1016/S0140-6736(98) 10411-7
10. Thisyakorn U, Khongphatthanayothin M, Sirivichayakul S, Rongkavilit C, Poolcharoen W, Kunanusont C, et al. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen. AIDS 2000; 14: 2921-7. doi:10.1097/00002030-20001 2220-00014
11. Kanshana S, Simonds RJ. National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned. AIDS 2002; 16: 953-9. doi:10.1097/00002030-200205030-00001
12. Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr 2009; 50: 506-12. doi:10.1097/QAI.0b013e3181967602
13. Over M, Revenga A, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, et al. The economics of effective AIDS treatment in Thailand. AIDS 2007; 21: S105-16. doi:10.1097/01. aids.0000279713.39675.1c
14. Beall R, Kuhn R. Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. PLoS Med 2012; 9: e1001154. doi:10.1371/journal.pmed.1001154
15. Condon BJ, Sinha T. Global lessons from the AIDS pandemic: economic, financial, legal, and political implications, 2nd edn. Berlin: Springer Verlag; 2010.
16. HIV AIDS Asia Pacific Research Statistical Data Information Resources. AIDS data hub. Geneva: Joint United Nations Programme on HIV/AIDS; 2013. Available online at: http://www. aidsdatahub.org [verified March 2014].
17. Surasiengsunk S, Kiranandana S, Wongboonsin K, Garnett GP, Anderson RM, van Griensven F. Demographic impact of the HIV epidemic in Thailand. AIDS 1998; 12: 775-84. doi:10.1097/ 00002030-199807000-00014
18. Thai Working Group on HIV/AIDS Projections. Asian Epidemic Model (AEM), projections for HIV/AIDS in Thailand, 2005-2025. Bangkok: Family Health International and Bureau of AIDS, TB and STI, Department of Disease Control, Ministry of Public Health; 2008.
19. Sungkanuparph S, Techasathit W, Utaipiboon C, Chasombat S, Bhakeecheep S, Leechawengwongs M, et al. Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomed. 2010; 4: 515-28.
20. UN General Assembly Special Sessions. Thailand global AIDS response progress report 2012. Nonthaburi: National AIDS Committee Thailand; 2012. Available online at: http://www. aidsdatahub.org/dmdocuments/UNGASS-2012- Thailand-Narrative- Report.pdf [verified July 2013].
21. Traisupa A, Wongba C, Taylor DN. AIDS and prevalence of antibody to human immunodeficiency virus (HIV) in high risk groups in Thailand. Genitourin Med 1987; 63: 106-8.
22. Phanuphak P, Locharernkul C, Panmuong W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol 1985; 3: 195-9.
23. Weniger BG, Limpakarnjanarat K, Ungchusak K, Thanprasertsuk S, Choopanya K, Vanichseni S, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5: S71-85. doi:10.1097/00002030-199101001-00011
24. Ubol S, Phanuphak P, Traisupa A. Anti-HIV positivity in Thailand: the usefulness of another ELISA test kit and Western blot as confirmatory tests. Asian Pac J Allergy Immunol 1987; 5: 5-11.
25. Kitayaporn D, Uneklabh C, Weniger BG, Lohsomboon P, Kaewkungwal J, Morgan WM, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994; 8: 1443-50. doi:10.1097/00002030-199410000-00011
26. Ministry of Public Health. Results of sentinel HIV surveillance in Thailand. Round 1-30, 1988-2012. Nonthaburi: Bureau of Epidemiology, Department of Disease Control Ministry of Public Health; 2012. Available online at: http://www.boe.moph.go.th/ report.php? cat=20 [verified July 2013].
27. Royal Thai Army. Results of biannual HIV surveillance among Thai military recruits, 1989-2012. Bangkok: Pramongkutklao College of Medicine; 2013. Available online at: http://www.boe.moph.go.th/ files/report/20130430-40153271. pdf [verified July 2013].
28. Mason CJ, Markowitz LE, Kitsiripornchai S, Jugsudee A, Sirisopana N, Torugsa K, et al. Declining prevalence of HIV-1 infection in young Thai men. AIDS 1995; 9: 1061-5. doi:10.1097/00002030- 199509000-00012
29. Phanuphak P. AIDS perspectives. Thailand 1989. Asian Pac J Allergy Immunol 1988; 6: 67-9. [Editorial]
30. Celentano DD, Akarasewi P, Sussman L, Suprasert S, Matanasarawoot A, Wright NH, et al. HIV-1 infection among lower class commercial sex workers in Chiang Mai, Thailand. AIDS 1994; 8: 533-7. doi:10.1097/00002030-199404000-00018
31. Limanonda B, van Griensven GJ, Chongvatana N, Tirasawat P, Coutinho RA, Wattana A, et al. Condom use and risk factors for HIV-1 infection among female commercial sex workers in Thailand. Am J Public Health 1994; 84: 2026-7. doi:10.2105/AJPH.84.12. 2026
32. Lyttleton C. Messages of distinction: the HIV/AIDS media campaign in Thailand. Med Anthropol 1994; 16: 363-89. doi:10.1080/01459 740.1994.9966122
33. Mastro TD, Limpakarnjanarat K. Condom use in Thailand: how much is it slowing the HIV/AIDS epidemic? AIDS 1995; 9: 523-5. doi:10.1097/00002030- 199509050-00016
34. Morris M, Pramualratana A, Podhisita C, Wawer MJ. The relational determinants of condom use with commercial sex partners in Thailand. AIDS 1995; 9: 507-15. doi:10.1097/00002030-199509 050-00014
35. Muller O, Sarangbin S, Ruxrungtham K, Sittitrai W, Phanuphak P. Sexual risk behaviour reduction associated with voluntary HIV counselling and testing in HIV infected patients in Thailand. AIDS Care 1995; 7: 567-72. doi:10.1080/09540129550126227
36. Sweat MD, Nopkesorn T, Mastro TD, Sangkharomya S, MacQueen K, Pokapanichwong W, et al. AIDS awareness among a cohort of young Thai men: exposure to information, level of knowledge, and perception of risk. AIDS Care 1995; 7: 573-92. doi:10.1080/ 09540129550126236
37. van Griensven GJ, Limanonda B, Chongwatana N, Tirasawat P, Coutinho RA. Socio-economic and demographic characteristics and HIV-1 infection among female commercial sex workers in Thailand. AIDS Care 1995; 7: 557-65. doi:10.1080/09540129550 126218
38. Nelson KE, Celentano DD, Eiumtrakol S, Hoover DR, Beyrer C, Suprasert S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996; 335: 297-303. doi:10.1056/NEJM199608013350501
39. Kilmarx PH, Limpakarnjanarat K, Mastro TD, Saisorn S, Kaewkungwal J, Korattana S, et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS 1998; 12: 1889-98. doi:10.1097/00002030-199814000-00021
40. Siriwasin W, Shaffer N, Roongpisuthipong A, Bhiraleus P, Chinayon P, Wasi C, et al. HIV prevalence, risk, and partner serodiscordance among pregnant women in Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group. JAMA 1998; 280: 49-54. doi:10.1001/jama.280.1.49
41. Svenkerud PJ, Singha A. Enhancing the effectiveness of HIV/ AIDS prevention programs targeted to unique population groups in Thailand: lessons learned from applying concepts of diffusion of innovation and social marketing. J Health Commun 1998; 3: 193-216. doi:10.1080/108107398127337
42. Kitsiripornchai S, Markowitz LE, Ungchusak K, Jenkins RA, Leucha W, Limpitaks T, et al. Sexual behavior of young men in Thailand: regional differences and evidence of behavior change. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 282-8. doi:10.1097/ 00042560-199807010-00013
43. van Griensven GJ, Limanonda B, Ngaokeow S, Ayuthaya SI, Poshyachinda V. Evaluation of a targeted HIV prevention programme among female commercial sex workers in the south of Thailand. Sex Transm Infect 1998; 74: 54-8. doi:10.1136/sti.74.1.54
44. Chamratrithirong A, Thongchai V, Boonchalaksi W, Guest P, Khunchanachitra C, Varangrat A. The success of the 100% condom use programme in Thailand: survey results of the evaluation of the 100% condom use programme in Thailand. Nakorn Pathom: Mahidol University; 1999.
45. Limpakarnjanarat K, Mastro TD, Saisorn S, Uthaivoravit W, Kaewkungwal J, Korattana S, et al. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Transm Infect 1999; 75: 30-5. doi:10.1136/ sti.75.1.30
46. Celentano DD, Bond KC, Lyles CM, Eiumtrakul S, Go VF, Beyrer C, et al. Preventive intervention to reduce sexually transmitted infections: a field trial in the Royal Thai Army. Arch Intern Med 2000; 160: 535-40. doi:10.1001/ archinte.160.4.535
47. Kilmarx PH, Supawitkul S, Wankrairoj M, Uthaivoravit W, Limpakarnjanarat K, Saisorn S, et al. Explosive spread and effective control of human immunodeficiency virus in northernmost Thailand: the epidemic in Chiang Rai province, 1988-99. AIDS 2000; 14: 2731-40. doi:10.1097/00002030-20001 2010-00013
48. Hanenberg R, Rojanapithayakorn W. Changes in prostitution and the AIDS epidemic in Thailand. AIDS Care 1998; 10: 69-79. doi:10.1080/713612352
49. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991; 5: 1509-13. doi:10.1097/00002030-199112000-00014
50. Celentano DD, Jittiwutikorn J, Hodge MJ, Beyrer C, Nelson KE. Epidemiology of HIV-1 infection in opiate users in Northern Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 73-8. doi:10.1097/00042560- 199801010-00011
51. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, Des Jarlais DC, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS 2001; 15: 397-405. doi:10.1097/00002030-200102160-00013
52. Choopanya K, Des Jarlais DC, Vanichseni S, Kitayaporn D, Mock PA, Raktham S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Synd. 2002; 29: 86-94. doi:10.1097/00126334- 200201010-00012
53. Beyrer C, Jittiwutikarn J, Teokul W, Razak MH, Suriyanon V, Srirak N, et al. Drug use, increasing incarceration rates, and prisonassociated HIV risks in Thailand. AIDS Behav 2003; 7: 153-61. doi:10.1023/A:1023946324822
54. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003; 326: 308. doi:10.1136/bmj.326. 7384.308
55. Vanichseni S, Des Jarlais DC, Choopanya K, Mock PA, Kitayaporn D, Sangkhum U, et al. Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr 2004; 37: 1170-9. doi:10.1097/01.qai.0000120821.38576.ec
56. Vanichseni S, Tappero JW, Pitisuttithum P, Kitayaporn D, Mastro TD, Vimutisunthorn E, et al. Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS 2004; 18: 311-6. doi:10.1097/00002030-200401230-00022
57. van Griensven F, Vanichseni S, Pitisuttithum P, Wichienkuer P, Tappero JW, Sangkum U, et al. Trends in the injection of midazolam and other drugs among injection drug users enrolled in the AIDSVAX B/E HIV-1 vaccine trial in Bangkok, Thailand. Int J Drug Policy 2005; 16: 171-5. doi:10.1016/j.drugpo.2005. 02.003
58. Hayashi K, Milloy MJ, Fairbairn N, Kaplan K, Suwannawong P, Lai C, et al. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health 2009; 9: 492. doi:10.1186/1471- 2458-9-492
59. Kerr T, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, Zhang R, et al. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand. Drug Alcohol Rev 2010; 29: 157-61. doi:10.1111/j.1465- 3362.2009.00093.x
60. Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R, et al. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre. Int J Drug Policy 2010; 21: 255-8. doi:10.1016/j. drugpo.2009.08.002
61. Kerr T, Kiatying-Angsulee N, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, et al. High rates of midazolam injection among drug users in Bangkok, Thailand. Harm Reduct J 2010; 7: 7. doi:10.1186/1477-7517-7-7
62. Mastro TD, Kitayaporn D, Weniger BG, Vanichseni S, Laosunthorn V, Uneklabh T, et al. Estimating the number of HIV-infected injection drug users in Bangkok: a capture-recapture method. Am J Public Health 1994; 84: 1094-9. doi:10.2105/AJPH.84.7.1094
63. Wattana W, van Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, Bannatham R, et al. Respondentdriven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alc Depend. 2007; 90: 228-3. doi:10.1016/j.drugalcdep.2007.03.013
64. Johnston LG, Prybylski D, Raymond HF, Mirzazadeh A, Manopaiboon C, McFarland W. Incorporating the service multiplier method in respondent-driven sampling surveys to estimate the size of hidden and hard-to-reach populations: case studies from around the world. Sex Transm Dis 2013; 40: 304-10. doi:10.1097/OLQ.0b013e31827fd650
65. Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users: epidemiology, causes and intervention. Cambridge, UK: Cambridge University Press; 2007.
66. Rangsin R, Chiu J, Khamboonruang C, Sirisopana N, Eiumtrakul S, Brown AE, et al. The natural history of HIV-1 Infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr 2004; 36: 622-9. doi:10.1097/00126334-200405010-00011
67. Wolfe D, Cohen J. Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr 2010; 55: S56-62. doi:10.1097/ QAI.0b013e3181f9c0de
68. Anonymous. Thailand - not enough graves: the war on drugs, HIV/ AIDS, and violations of human rights. Human Rights Watch. 2004; 16. Available from: http://www.hrw.org/reports/2004/thailand0704/ thailand0704.pdf [verified 23 May 2014].
69. Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Chuachoowong R, Mock PA, et al. Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand. PLoS ONE 2011; 6: e25127. doi:10.1371/journal.pone.0025127
70. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebocontrolled phase 3 trial. Lancet 2013; 381: 2083-90. doi:10.1016/ S0140-6736(13)61127-7
71. Sittitrai W, Phanuphak P, Barry J, Brown T. Thai sexual behavior and risk of HIV infection: report of the 1990 survey of partner relations and risk of HIV infection in Thailand. Bangkok: Thai Red Cross Society and Institute of Population Studies, Chulalongkorn University; 1992.
72. Beyrer C, Eiumtrakul S, Celentano DD, Nelson KE, Ruckphaopunt S, Khamboonruang C. Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. AIDS 1995; 9: 171-6. doi:10.1097/00002030- 199509020-00009
73. London AS, VanLandingham MJ, Grandjean N. Socio-demographic correlates, HIV/AIDS-related cofactors, and measures of same-sex sexual behaviour among northern Thai male soldiers. Health Transit Rev 1997; 7: 33-60.
74. van Griensven F, Kilmarx PH, Jeeyapant S, Manopaiboon C, Korattana S, Jenkins RA, et al. The prevalence of bisexual and homosexual orientation and related health risks among adolescents in northern Thailand. Arch Sex Behav 2004; 33: 137-47. doi:10.1023/ B:ASEB.0000014328.49070.8c
75. Sureerut R, Assanangkornchai S, Chongsuvivatwong V, Duangmala P. Sexual orientation and sexual risk behaviors among male students of a university in southern Thailand. J Med Assoc Thai 2013; 96: 1224-8.
76. National Statistical Office. Ministry of Information and Communication Technology (MICT). Statistical yearbook Thailand 2012. Bangkok; MICT; 2012. Available online at: http:// service.nso.go.th/nso/nso-center/project/search- center/23project-en. htm [verified May 2014].
77. The NESDB Working Group on HIV/AIDS Projection. Projections for HIV/AIDS in Thailand: 1987-2020. Bangkok: Thai Red Cross Society Program on AIDS; 1994.
78. van Griensven F, Thanprasertsuk W, Jommaroeng R, Mansergh G, Naorat S, Jenkins RA, et al. Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS 2005; 19: 521-6. doi:10.1097/01. aids.0000162341.50933.e8
79. van Griensven F, Varangrat A, Wimonsate W, Tanpradech S, Kladsawad K, Chemnasiri T, et al. Trends in HIV prevalence, estimated HIV incidence and risk behavior among men who have sex with men in Bangkok, Thailand, 2003-2007. J Acquir Immune Defic Syndr 2010; 53: 234-9. doi:10.1097/QAI.0b013e3181c2fc86
80. Kladsawas K, Yodrien K, Kittisunrobus S, Tjarupun S, Namwat S, Plipat T. Results of venue-based HIV surveillance among men who have sex with men in Thailand, 2010. Nonthaburi: Ministry of Public Health, Department of Disease Control, Bureau of Epidemiology; 2010. [In Thai]
81. Bureau of Epidemiology. Results of venue-based HIV surveillance among men who have sex with men in Thailand, 2012. Nonthaburi: Ministry of Public Health, Department of Disease Control; 2012. [In Thai]
82. Phanuphak N, Pattanachaiwit S, Pankam T, Pima W, Avihingsanon A, Teeratakulpisarn N, et al. Active voluntary counseling and testing with integrated CD4 count service can enhance early HIV testing and early CD4 count measurement: experiences from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. J Acquir Immune Defic Syndr 2011; 56: 244-52. doi:10.1097/QAI. 0b013e318207597f
83. Ananworanich J, Chitwarakorn A, Wimonsate W, Varangrat A, Chaikummao S, Sriporn A, et al. HIV and syphilis infection among men who have sex with men - Bangkok, 2005-2011. Morb Mortal Wkly Rep 2013; 62: 518-20.
84. van Griensven F, Thienkrua W, McNicholl J, Wimonsate W, Chaikummao S, Chonwattana W, et al. Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. AIDS 2013; 27: 825-32. doi:10.1097/QAD.0b013e 32835c546e
85. Chariyalertsak S, Kosachunhanan N, Saokhieo P, Songsupa R, Wongthanee A, Chariyalertsak C, et al. HIV incidence, risk factors, and motivation for biomedical intervention among gay, bisexual men, and transgender persons in Northern Thailand. PLoS ONE 2011; 6: e24295. doi:10.1371/journal.pone.0024295
86. van Griensven F, Varangrat A, Wimolsate W, Tappero JW, Sinthuwattanawibool C, McNicholl JM, et al. HIV prevalence among populations of men who have sex with men - Thailand, 2003 and 2005. Morb Mortal Wkly Rep 2006; 31: 844-8.
87. Nitayaphan S, Benenson M, Sriplienchan S, Morgan P, Eamsila C, Chiu J, et al. ECHO Study (Early Capture HIV Cohort): efficient detection of acute HIV-1 infections in Pattaya, Thailand (RV 217). In: Abstracts from AIDS Vaccine; 28 September-1 October 2010; Atlanta, USA. 2010. Abstract P01-02. Available online at: http://online.liebertpub.com/doi/abs/10.1089%2Faid.2010. 9998 [verified June 2014].
88. Ananworanich J, Phanuphak N, de Souza M, Paris R, Arroyo M, Trichavaroj R, et al. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr 2008; 49: 151-5. doi:10.1097/QAI.0b013e318183a96d
89. Kunawararak P, Beyrer C, Natpratan C, Feng W, Celentano DD, de Boer M, et al. The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand. AIDS 1995; 9: 517-21. doi:10.1097/00002030-199509050-00015
90. Guadamuz TE, Kunawararak P, Beyrer C, Pumpaisanchai J, Wei C, Celentano DD. HIV prevalence, sexual and behavioral correlates among Shan, Hill tribe, and Thai male sex workers in Northern Thailand. AIDS Care 2010; 22: 597-605. doi:10.1080/0954012 0903280935
91. Rosenfield A, Bennett A, Varakamin S, Lauro D. Thailand's family planning program: an Asian success story. Int Fam Plan Perspect 1982; 8: 43-51. doi:10.2307/2948087
92. Knodel J, Havanon N, Pramualratana A. Fertility transition in Thailand: a qualitative analysis. Popul Dev Rev 1984; 10: 297-328. doi:10.2307/1973084
93. Knodel J, Chamratrithirong A, Debavalya N. Thailand's reproductive revolution. Madison: University of Wisconsin Press; 1987.
94. Knodel J. Thailand's reproductive revolution. Soc Sci 1987; 72: 52-6.
95. Reyes D. Population and health policies in Thailand and the Philippines: a comparative study. Lessons from Thailand's experience. Bangkok: Asian Scholarship Foundation; 2004.
96. Porapakkham Y, Pramarnpol S, Athibhoddhi S. Bernard R. The evolution of HIV/AIDS policy in Thailand: 1984-1994. Nakorn Pathom: ASEAN Institute for Health Development, Mahidol University; 1995.
97. D'Agnes T. From condoms to cabbages: an authorized biography of Mechai Viravaidya. Bangkok: Post Books; 2001.
98. Bristol N. Mechai Viravaidya: Thailand's 'condom king'. Lancet 2008; 371: 109. doi:10.1016/S0140-6736(08)60091-4
99. Smith GL, Smith KF. Lack of HIV infection and condom use in licensed prostitutes. Lancet 1986; 328: 1392. doi:10.1016/S0140- 6736(86)92028-3
100. Mann J, Quinn TC, Piot P, Bosenge N, Nzilambi N, Kalala M, et al. Condom use and HIV infection among prostitutes in Zaire. N Engl J Med 1987; 316: 345. doi:10.1056/NEJM198702053160615
101. Condoms for prevention of sexually transmitted diseases. Morb Mortal Wkly Rep 1988; 37: 133-7.
102. Darrow WW. Condom use and use-effectiveness in high-risk populations. Sex Transm Dis 1989; 16: 157-60. doi:10.1097/ 00007435-198907000-00008
103. Voeller B, Nelson J, Day G. Viral leakage risk differences in latex condoms. AIDS Res Hum Retroviruses 1994; 10: 701-10. doi:10.1089/aid.1994.10.701
104. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44: 1303-12. doi:10.1016/S0277-9536(96)00258-4
105. Jittjang S, Girault P. Targeted multi-media campaign reaching MSM in Bangkok and Chiang Mai in Thailand: a relevant strategy to increase the coverage and contribute to the effectiveness of interventions reaching MSM. In: Proceedings of the XVII International AIDS Conference; 3-8 August 2008; Mexico City, Mexico. 2008. Abstract THPE0352Available online at: http://www. iasociety.org/AbstractSearch.aspx [verified June 2014].
106. Kelly JA, St Lawrence J, Diaz YE, Stevenson LY, Hauth AC, Brasfield TL, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health 1991; 81: 168-71. doi:10.2105/AJPH.81.2.168
107. Spratt K, Escobar MC. Increasing access and uptake of HIV testing and counseling among men who have sex with men in Thailand. Arlington, VA: USAID's AIDS Support and Technical Assistance Resources, AIDSTAR-One, Task Order 1; 2011.
108. National AIDS Management Center. UNGASS Thailand AIDS response progress report 2012: status at a glance. Bangkok: Ministry of Public Health; 2012.
109. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505. doi:10.1056/NEJMoa1105243
110. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363: 2587-99. doi:10.1056/ NEJMoa1011205
111. Thai Red Cross AIDS Research Center (TRARC). The Thai Red Cross AIDS Research Center. Bangkok: TRARC; 2012. Available online at: http://en.trcarc. org/ [verified February 2014].
112. Research Institute for Health Sciences (RIHS). Research Institute for Health Sciences. Chiang Mai: RIHS, Chiang Mai University; 2012. Available online at: http://www.rihes.cmu.ac.th/ [verified February 2014].
113. Armed Forces Research Institute for Medical Sciences (AFRIMS). AFRIMS. Bangkok: AFRIMS; 2013. Available online at: http:// www.afrims.org/ [verified February 2014].
114. Partners in Progress. Annual report 2009-2010. Thailand MOPH- US CDC Collaboration. 2010. Available online at: http://photos. state.gov/libraries/ thailand/33889/PDFs/biennial-report-0910-mop h-cdc-english.pdf [verified February 2014].
115. Programs in HIV Prevention and Treatment-International Research Unit. Welcome to PHPT. Chiang Mai: PHPT; 2013. Available online at: http://www.phpt.org/ [verified May 2014].
116. HIV Netherlands Australia Thailand Research Collaboration (HIVNAT). The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT). Bangkok: HIVNAT; 2014. Available online at: http://www.hivnat.org/en/ [verified February 2014].
117. South East Asia Research Collaboration with Hawaii (SEARCH). About us. Bangkok: SEARCH; 2006. Available online at: http:// www.searchthailand.org/ [verified February 2014].
118. Sawanpanyalert P, Ungchusak K, Thanparsertsuk S, Akarasewi P. Seroconversion rate and risk factors for HIV-1 infection among low class female sex workers in Chiang Mai, Thailand. AIDS 1994; 8: 825-9.
119. Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, et al. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS 1995; 9: 1079-84. doi:10.1097/00002030- 199509000-00015
120. Beyrer C, Artenstein WW, Rugpao S, Stephens H, VanCott TC, Robb M, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999; 179: 59-67. doi:10.1086/314556
121. Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, et al. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS ONE 2012; 7: e29231. doi:10.1371/ journal.pone.0029231
122. Kilmarx PH, van de Wijgert JH, Chaikummao S, Jones HE, Limpakarnjanarat K, Friedland BA. Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a phase II clinical trial. J Acquir Immune Defic Syndr 2006; 43: 327-34. doi:10.1097/01.qai.0000243056.59860.c1
123. HIV Prevention Trials Network (HPTN). HPTN 067. The ADAPT study. Durham, NC: HPTN; 2012. Available online at: http://www. hptn.org/research-studies/ hptn067.asp [verified August 2013].
124. Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006; 194: 1661-71. doi:10.1086/508748
125. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361: 2209-20. doi:10.1056/NEJMoa0908492
126. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80. doi:/pdf/10.1056/NEJM19941103 3311801
127. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353: 786-92. doi:10.1016/S0140-6736(98)11046-2
128. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET012 randomised trial. Lancet 1999; 354: 795-802. doi:10.1016/S0140- 6736(99)80008-7
129. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short-course oral zidovudine for prevention of motherto- child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999; 353: 781-5. doi:10.1016/S0140- 6736(98)10412-9
130. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005; 2: e298. doi:10.1371/journal.pmed. 0020298
131. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643-56. doi:10.1016/S0140-6736(07)60312-2
132. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369: 657-66. doi:10.1016/S0140-6736(07)60313-4
133. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367: 399-410. doi:10.1056/ NEJMoa1108524
134. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367: 423-34. doi:10.1056/NEJMoa1110711
135. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168-74. doi:10.1126/science. 1193748
136. Flynn NM, Forthal DN, Harrow CD, Judson FN, Mayer KH, Para MF. Placebo-controlled phase3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 2005; 191: 654-65. doi:10.1086/428404
137. Robertson M, Mehrotra D, Fitzgerald D, Duerr A, Casimiro D, McElrath J, et al. Efficacy results from the STEP study (Merck V520 protocol 023/HVTN 502): a phase II test-of-concept trial of the MRKAd5 HIV-1 gag/pol/nef trivalent vaccine. Seattle: HIV Vaccine Trials Network; 2008. Available online at: http://www.hvtn.org/ science/step-buch.html [verified August 2013].
138. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-10. doi:10.1056/ NEJM199808203390803
139. van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-7. doi:10.1016/S0140- 6736(02)11079-8
140. Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, et al. SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE 2007; 2: e1312. doi:10.1371/journal.pone.0001312
141. Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE 2008; 3: e1474. doi:10.1371/journal.pone. 0001474
142. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1977-87. doi:10.1016/ S0140-6736(08)61842-5
143. van Damme L, Govinden R, Mirembe FM, Guedou F, Solomon S, Becker ML, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359: 463-72. doi:10.1056/NEJMoa0707957
144. Halpern V, Ogunsola F, Obunge O, Wang CH, Onyejepu N, Oduyebo O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria. PLoS ONE 2008; 3: e3784. doi:10.1371/journal.pone. 0003784
145. McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (microbicides development programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376: 1329-37. doi:10.1016/S0140-6736(10)61086-0
146. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; 25: 957-66. doi:10.1097/QAD.0b013e32834541d9
147. van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012; 367: 411-22. doi:10.1056/NEJMoa 1202614
148. Microbicide Trials Network (MTN). Questions and answers - results. The results of VOICE: vaginal and oral interventions to control the epidemic. Pittsburgh: MTN; 2013. Available online at: http://www.mtnstopshiv.org/news/ studies/mtn003/qa [verified August 2013].
149. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362: 427-39. doi:10.1056/NEJMoa0904849
150. van Griensven F, Thienkrua W, Sukwicha W, Wimonsate W, Chaikummao S, Varangrat A, et al. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection. J Int AIDS Soc 2010; 13: 13. doi:10.1186/ 1758-2652-13-13
151. Lui A, Vittinghoff E, Irvin R, Kroboth L, Krakower D, Mimiaga M, et al. Sexual frequency and planning among at-risk MSM in the US: implications for daily vs. intermittent pre-exposure prophylaxis (PrEP). In: Proceedings of the Sixth IAS Conference; 17-20 July 2011; Rome, Italy. 2011. Abstract TUPE 362. Available online at: http://www.iasociety.org/AbstractSearch.aspx [verified June 2014].
152. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012; 4: 151ra25.
153. Microbicide Trials Network (MTN). MTN-017 Pittsburgh: MTN; 2013. Available online at: http://www.mtnstopshiv.org/news/studies/ mtn017 [verified August 2013].
154. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS ONE 2012; 7: e33948. doi:10.1371/journal.pone. 0033948
155. van Griensven F, Phanuphak N, Kroon E, Fletcher J, Pinyakorn S, Chomchey N, et al. Acute HIV infection detection and control reduces HIV infectiousness and transmission risk behavior among men who have sex with men in Bangkok, Thailand. In: Proceedings of the Seventh IAS Conference on HIV Pathogenesis, Treatment and Prevention;30 June-3 July 2013; Kuala Lumpur, Malaysia. 2013. Abstract no. WELBC03. Available online at: http://www.iasociety. org/AbstractSearch.aspx [verified June 2014]
156. Audelin AM, Cowan SA, Obel N, Nielsen C, Jørgensen L, Gerstoft J. Phylogenetics of the Danish HIV epidemic: the role of very late presenters in sustaining the epidemic. J Acquir Immune Defic Syndr 2013; 62: 102-8. doi:10.1097/QAI.0b013e318276becc
157. Ambrosioni J, Junier T, Delhumeau C, Calmy A, Hirschel B, Zdobnov E, et al. Impact of HAART on the molecular epidemiology of newly diagnosed HIV infections in Geneva. AIDS 2012; 26: 2079-86. doi:10.1097/QAD.0b013e32835805b6
158. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-9. doi:10.1086/512088
159. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Brown AJL. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 2008; 5: e50. doi:10.1371/journal.pmed.0050050
160. Freeman P, Walker BC, Harris DR, Garofalo R, Willard N, Ellen JM. Methamphetamine use and risk for HIV among young men who have sex with men in8 US cities. Arch Ped Adol Med. 2011; 165: 736-40. doi:10.1001/archpediatrics. 2011.118
161. Garofalo R, Mustanski BS, McKirnan DJ, Herrick A, Donenberg GR. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk. Arch Ped Adol Med. 2007; 161: 591-6. doi:10.1001/archpedi.161.6.591
162. Fisher DG, Reynolds GL, Napper LE. Use of crystal meth, Viagra and sexual behaviour. Curr Opin Infect Dis 2010; 23: 53-6. doi:10.1097/QCO. 0b013e328334de0b
163. Fisher DG, Malow R, Rosenberg R, Reynolds GL, Farrell N, Jaffe A. Recreational Viagra use and sexual risk among drug abusing men. Am J Infect Dis 2006; 2: 107-14. doi:10.3844/ajidsp.2006. 107.114
164. Huang Y, Nelson KE, Lin J, Yang C, Chang F, Lew-Ting C. Syphilis among men who have sex with men (MSM) in Taiwan: its association with HIV prevalence, awareness of HIV status, and use of antiretroviral therapy. AIDS Behav 2013; 17: 1406-14. doi:10.1007/s10461-012-0405-9
165. Carcelain G, Autran B. Immune interventions in HIV infection. Immunol Rev 2013; 254: 355-71. doi:10.1111/imr.12083
166. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 2013; 381: 2109-17. doi:10.1016/S0140-6736(13)60104-X
167. van Griensven F, Na Ayutthaya PP, Wilson E. HIV surveillance and prevention in transgender women. Lancet Infect Dis 2013; 13: 185-6. doi:10.1016/S1473-3099(12)70326-2
168. Robb ML, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Kunasol P, et al. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect Dis 2012; 12: 531-7. doi:10.1016/S1473-3099(12)70088-9
169. Robb ML. Planned vaccine trials to follow up on RV 144. US Military HIV Research Program. Session 10 Research Networks. Presented at the 4th INTEREST Workshop: International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Limited Settings; 26-29 May 2010; Maputo, Mozambique. Available online at: http://regist2.virologyeducation. com/2012/6int/docs/10- Robb.pdf verified May 2014].
170. US Military HIV Research Program (USMHRP). RV 144 publications. Bethesda: MHRP; 2013. Available online at: http:// www.hivresearch.org/research.php? ServiceID=13&SubServiceID=19 [verified August 2013].
171. Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, et al. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science 2004; 303: 316. doi:10.1126/ science.1094620
172. Cohen J. Shots in the dark: the wayward search for an AIDS vaccine. New York: Norton; 2001.
173. Garber DA, Silvestri G, Feinberg MB. Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect Dis 2004; 4: 397-413. doi:10.1016/S1473-3099(04)01056-4
174. McNeil JG, Johnston MI, Birx DL, Tramont EC. Policy rebuttal. HIV vaccine trial justified. Science 2004; 303: 961. doi:10.1126/ science.1096161
175. Kilmarx PH, Palanuvej T, Limpakarnjanarat K, Chitvarakorn A, St Louis ME, Mastro TD. Seroprevalence of HIV among female sex workers in Bangkok: evidence of ongoing infection risk after the "100% condom program" was implemented. J Acquir Immune Defic Syndr 1999; 21: 313-6. doi:10.1097/00126334- 199908010-00009
176. Nhurod P, Bollen LJ, Smutraprapoot P, Suksripanich O, Siangphoe U, Lolekha R, et al. Access to HIV testing for sex workers in Bangkok, Thailand: a high prevalence of HIV among street-based sex workers. Southeast Asian J Trop Med Public Health 2010; 41: 153-62.
177. Bureau of AIDS, TB and STIs, Department of Disease Control. National guidelines for implementing HIV prevention in men who have sex with men and transgender populations. Nonthaburi: Ministry of Public Health; 2013.